Microdosimetry for Targeted Alpha Therapy of Cancer
Open Access
- 4 September 2012
- journal article
- research article
- Published by Hindawi Limited in Computational and Mathematical Methods in Medicine
- Vol. 2012, 1-6
- https://doi.org/10.1155/2012/153212
Abstract
Targeted alpha therapy (TAT) has the advantage of delivering therapeutic doses to individual cancer cells while reducing the dose to normal tissues. TAT applications relate to hematologic malignancies and now extend to solid tumors. Results from several clinical trials have shown efficacy with limited toxicity. However, the dosimetry for the labeled alpha particle is challenging because of the heterogeneous antigen expression among cancer cells and the nature of short-range, high-LET alpha radiation. This paper demonstrates that it is inappropriate to investigate the therapeutic efficacy of TAT by macrodosimetry. The objective of this work is to review the microdosimetry of TAT as a function of the cell geometry, source-target configuration, cell sensitivity, and biological factors. A detailed knowledge of each of these parameters is required for accurate microdosimetric calculations.Keywords
This publication has 44 references indexed in Scilit:
- Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibodyPhysics in Medicine & Biology, 2011
- Panel discussion: do non-targeted effects impact the relation between microdosimetry and risk?Radiation Protection Dosimetry, 2010
- A database of frequency distributions of energy depositions in small-size targets by electrons and ionsRadiation Protection Dosimetry, 2010
- Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213–Lintuzumab (HuM195) for Acute Myeloid LeukemiaClinical Cancer Research, 2010
- Therapeutic Radionuclides: Biophysical and Radiobiologic PrinciplesSeminars in Nuclear Medicine, 2008
- Alpha-particles for targeted therapyAdvanced Drug Delivery Reviews, 2008
- Alpha-Particle Emitting Atomic Generator (Actinium-225)-Labeled Trastuzumab (Herceptin) Targeting of Breast Cancer SpheroidsClinical Cancer Research, 2004
- Tissue equivalence correction for silicon microdosimetry detectors in boron neutron capture therapyMedical Physics, 1998
- Simultaneous macro and micro dosimetry with MOSFETsIEEE Transactions on Nuclear Science, 1996
- Analytic microdosimetry for radioimmunotherapeutic alpha emittersMedical Physics, 1992